1 0

    FDA Preliminary Comments for Zolbetuximab.clzb (BLA 761365) February 7, 2023 and June 15, 2020

    FDA Preliminary Comments for Zolbetuximab.clzb (BLA 761365) February 7, 2023 and June 15, 2020

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: From the review of zolbetuximab.clzb (BLA 761365), I would like to request the preliminary comments issued by FDA on February 7, 2023 from a meeting request made on December 20, 2022 and the "Type C CMC Meeting Preliminary Comments" on June 15 2020.
    Tags: Pharma, BLA, 2023
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details